The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation

Objectives. We investigated the influence of spinal cord stimulation (SCS) on IFN-γ, IL-1β, IL-6, TNF-α, IL-10, and TGF-β serum levels in failed back surgery syndrome (FBSS) patients. The study will try to give new insights into the mechanism of SCS action and the role of IFN-γ and other cytokines i...

Full description

Bibliographic Details
Main Authors: Piotr Kamieniak, Joanna Bielewicz, Cezary Grochowski, Jakub Litak, Agnieszka Bojarska-Junak, Beata Daniluk, Tomasz Trojanowski
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Disease Markers
Online Access:http://dx.doi.org/10.1155/2019/2606808
id doaj-bc48b4fe7631471a886fc31d9521642d
record_format Article
spelling doaj-bc48b4fe7631471a886fc31d9521642d2020-11-24T23:07:44ZengHindawi LimitedDisease Markers0278-02401875-86302019-01-01201910.1155/2019/26068082606808The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord StimulationPiotr Kamieniak0Joanna Bielewicz1Cezary Grochowski2Jakub Litak3Agnieszka Bojarska-Junak4Beata Daniluk5Tomasz Trojanowski6Department of Neurosurgery, Medical University of Lublin, PolandDepartment of Neurology, Medical University of Lublin, PolandDepartment of Neurosurgery, Medical University of Lublin, PolandDepartment of Neurosurgery, Medical University of Lublin, PolandDepartment of Clinical Immunology, Medical University of Lublin, PolandInstitute of Psychology, Marie Curie-Skłodowska University in Lublin, PolandDepartment of Neurosurgery, Medical University of Lublin, PolandObjectives. We investigated the influence of spinal cord stimulation (SCS) on IFN-γ, IL-1β, IL-6, TNF-α, IL-10, and TGF-β serum levels in failed back surgery syndrome (FBSS) patients. The study will try to give new insights into the mechanism of SCS action and the role of IFN-γ and other cytokines in neuropathic pain (NP) development. Materials and Methods. Clinical and biochemical assessment was conducted in four groups of patients: group 0 consisted of 24 FBSS patients qualified to SCS therapy, group 1 included 17 patients who were one month after implantation, group 2 featured 12 patients who were 3 months after the implantation, and group C (the control group) with no NP. Clinical status was assessed with the use of Numeric Rating Scale (NRS), the Pain Rating Index of McGill Pain Questionnaire (SF-MPQ), the Oswestry Disability Index (ODI), and Beck Depression Inventory (BDI). The plasma concentrations of IFN-γ were ascertained by an immunoenzymatic method. Results. We found a significant difference between the patients before SCS and controls’ serum level of IFN-γ. Similarly, a significantly higher level of TNF-α and significantly lower level of IL-10 in FBSS patients than controls were observed. The significant differences were not observed between SCS patients 3 months after the procedure and controls’ serum level of IFN-γ and other cytokines. We noticed a positive correlation between IFN-γ concentration with NRS back value before SCS and positive correlation between IFN-γ concentration after SCS with NRS leg value before SCS. Higher IFN-γ concentrations accompanied higher NRS values. Levels of TGF-β and IL-10 may correlate with physical ability and depressive behavior. Conclusions. SCS did not influence serum cytokine levels significantly. Serum concentration of IFN-γ may be recognized as an occasional pain factor because of its significantly higher level in FBSS patients versus controls and higher IFN-γ value accompanying higher pain intensity.http://dx.doi.org/10.1155/2019/2606808
collection DOAJ
language English
format Article
sources DOAJ
author Piotr Kamieniak
Joanna Bielewicz
Cezary Grochowski
Jakub Litak
Agnieszka Bojarska-Junak
Beata Daniluk
Tomasz Trojanowski
spellingShingle Piotr Kamieniak
Joanna Bielewicz
Cezary Grochowski
Jakub Litak
Agnieszka Bojarska-Junak
Beata Daniluk
Tomasz Trojanowski
The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation
Disease Markers
author_facet Piotr Kamieniak
Joanna Bielewicz
Cezary Grochowski
Jakub Litak
Agnieszka Bojarska-Junak
Beata Daniluk
Tomasz Trojanowski
author_sort Piotr Kamieniak
title The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation
title_short The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation
title_full The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation
title_fullStr The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation
title_full_unstemmed The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation
title_sort elevated serum level of ifn-γ in patients with failed back surgery syndrome remains unchanged after spinal cord stimulation
publisher Hindawi Limited
series Disease Markers
issn 0278-0240
1875-8630
publishDate 2019-01-01
description Objectives. We investigated the influence of spinal cord stimulation (SCS) on IFN-γ, IL-1β, IL-6, TNF-α, IL-10, and TGF-β serum levels in failed back surgery syndrome (FBSS) patients. The study will try to give new insights into the mechanism of SCS action and the role of IFN-γ and other cytokines in neuropathic pain (NP) development. Materials and Methods. Clinical and biochemical assessment was conducted in four groups of patients: group 0 consisted of 24 FBSS patients qualified to SCS therapy, group 1 included 17 patients who were one month after implantation, group 2 featured 12 patients who were 3 months after the implantation, and group C (the control group) with no NP. Clinical status was assessed with the use of Numeric Rating Scale (NRS), the Pain Rating Index of McGill Pain Questionnaire (SF-MPQ), the Oswestry Disability Index (ODI), and Beck Depression Inventory (BDI). The plasma concentrations of IFN-γ were ascertained by an immunoenzymatic method. Results. We found a significant difference between the patients before SCS and controls’ serum level of IFN-γ. Similarly, a significantly higher level of TNF-α and significantly lower level of IL-10 in FBSS patients than controls were observed. The significant differences were not observed between SCS patients 3 months after the procedure and controls’ serum level of IFN-γ and other cytokines. We noticed a positive correlation between IFN-γ concentration with NRS back value before SCS and positive correlation between IFN-γ concentration after SCS with NRS leg value before SCS. Higher IFN-γ concentrations accompanied higher NRS values. Levels of TGF-β and IL-10 may correlate with physical ability and depressive behavior. Conclusions. SCS did not influence serum cytokine levels significantly. Serum concentration of IFN-γ may be recognized as an occasional pain factor because of its significantly higher level in FBSS patients versus controls and higher IFN-γ value accompanying higher pain intensity.
url http://dx.doi.org/10.1155/2019/2606808
work_keys_str_mv AT piotrkamieniak theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation
AT joannabielewicz theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation
AT cezarygrochowski theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation
AT jakublitak theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation
AT agnieszkabojarskajunak theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation
AT beatadaniluk theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation
AT tomasztrojanowski theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation
AT piotrkamieniak elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation
AT joannabielewicz elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation
AT cezarygrochowski elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation
AT jakublitak elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation
AT agnieszkabojarskajunak elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation
AT beatadaniluk elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation
AT tomasztrojanowski elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation
_version_ 1725617322757980160